Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
企業コードBLCO
会社名Bausch + Lomb Corp
上場日May 06, 2022
最高経営責任者「CEO」Mr. Brenton L. (Brent) Saunders, J.D.
従業員数13500
証券種類Ordinary Share
決算期末May 06
本社所在地520 Applewood Crescent
都市VAUGHAN
証券取引所NYSE Consolidated
国Canada
郵便番号L4K 4B4
電話番号19082552864
ウェブサイトhttps://ir.bausch.com/
企業コードBLCO
上場日May 06, 2022
最高経営責任者「CEO」Mr. Brenton L. (Brent) Saunders, J.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし